HEMATOLOGICAL MALIGNANCIES WITH THROMBOCYTOPENIA UNDERGOING PRIMARY PERCUTANEOUS PERICARDIOCENTESIS: PERIPROCEDURAL (30-DAY) OVERALL SURVIVAL ANALYSIS

Astrid Serauto,Michelle Lee,Juan C. Lopez-Mattei,Clarence Gill,Teodora Donisan,Dinu Balanescu,Konstantinos Marmagkiolis,Nicolas Palaskas,Peter Y. Kim,Anita Deswal,Cezar Iliescu

Journal of the American College of Cardiology（2020）

引用 0|浏览35

暂无评分

摘要

Thrombocytopenia (TCP) is a common finding in cancer patients and traditionally has been considered a relative contraindication to pericardiocentesis (PC). This study analyzed the prognostic factors and overall survival of PC in TCP patients with diagnosis of hematologic malignancy. A retrospective

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要